WELLINGTON MANAGEMENT GROUP LLP - ROYALTY PHARMA PLC ownership

ROYALTY PHARMA PLC's ticker is RPRX and the CUSIP is G7709Q104. A total of 2 filers reported holding ROYALTY PHARMA PLC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
WELLINGTON MANAGEMENT GROUP LLP ownership history of ROYALTY PHARMA PLC
ValueSharesWeighting
Q3 2023$2,454,705
-12.4%
90,446
-0.8%
0.00%
-100.0%
Q2 2023$2,803,304
+48.9%
91,194
+74.5%
0.00%
Q1 2023$1,882,567
-98.6%
52,250
-98.5%
0.00%
-100.0%
Q4 2022$134,009,199
-15.6%
3,390,921
-14.2%
0.03%
-20.6%
Q3 2022$158,756,000
+12.2%
3,951,117
+17.4%
0.03%
+21.4%
Q2 2022$141,447,000
+17.1%
3,364,603
+8.5%
0.03%
+33.3%
Q1 2022$120,769,000
-2.4%
3,099,830
-0.2%
0.02%
+5.0%
Q4 2021$123,747,000
+9.5%
3,105,308
-0.7%
0.02%
+5.3%
Q3 2021$113,061,000
-35.9%
3,128,405
-27.3%
0.02%
-34.5%
Q2 2021$176,402,000
-17.4%
4,303,526
-12.0%
0.03%
-23.7%
Q1 2021$213,436,000
-27.3%
4,893,133
-16.6%
0.04%
-29.6%
Q4 2020$293,741,000
+22.5%
5,868,929
+3.0%
0.05%
+8.0%
Q3 2020$239,804,000
-11.9%
5,700,113
+1.7%
0.05%
-18.0%
Q2 2020$272,148,0005,605,5310.06%
Other shareholders
ROYALTY PHARMA PLC shareholders Q4 2023
NameSharesValueWeighting ↓
Siguler Guff Advisers, LLC 3,391,754$122,204,89747.65%
Vantage Consulting Group Inc 1,022,194$36,829,65020.91%
Indie Asset Partners, LLC 433,000$15,600,99018.22%
Overbrook Management Corp 578,783$20,853,5515.46%
Silicon Valley Community Foundation 1,032,320$37,194,4905.36%
SUVRETTA CAPITAL MANAGEMENT, LLC 3,047,049$109,785,1754.64%
Geo Capital Gestora de Recursos Ltd 142,748$5,1433.81%
Renaissance Capital LLC 123,913$4,464,5853.31%
Rokos Capital Management LLP 1,106,813$40,077,6982.96%
Lagoda Investment Management, L.P. 101,500$3,657,0452.60%
View complete list of ROYALTY PHARMA PLC shareholders